Magnetic hydroxyapatite nanomaterial–cyclodextrin tethered polymer hybrids as anticancer drug carriers-Reference-Cited by-同舟云学术

Magnetic hydroxyapatite nanomaterial–cyclodextrin tethered polymer hybrids as anticancer drug carriers

Published:2021 Issue: Volume: Page:
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Ramasamy Sivaraj¹²³⁴,Dhamecha Dinesh⁵⁶⁷⁸⁹,Kaliyamoorthi Kiruthiga¹⁰¹¹¹²¹³,Pillai Archana Sumohan¹⁴¹⁵¹⁶¹³,Alexander Aleyamma¹⁴¹⁵¹⁶¹³,Dhanaraj Premnath¹⁷¹⁵¹⁶¹³,Menon Jyothi U.⁵⁶⁷⁸⁹^ORCID,Enoch Israel V. Muthu Vijayan¹⁴¹⁵¹⁶¹³^ORCID

Affiliation:

1. Functional polymers and Materials Laboratory

2. Department of Smart Green Technology and Engineering

3. Pukyong National University

4. South Korea

5. Department of Biomedical and Pharmaceutical Sciences

6. College of Pharmacy

7. University of Rhode Island

8. Kingston

9. USA

10. Department of Chemistry and Department of Chemical Engineering

11. Hindustan Institute of Technology and Science

12. Chennai 603103

13. India

14. Centre for Nanoscience and Genomics

15. Karunya Institute of Technology and Sciences

16. Coimbatore 641114

17. Department of Biotechnology

Abstract

Osteosarcoma, the most common bone cancer, leads to a poor survival rate of patients. Drug targeting employing hydroxyapatite (HAp)-based nanocarriers represents a fascinating choice for non-invasive treatment of osteosarcoma.

Funder

Board of Research in Nuclear Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

Microbiology

Link

http://pubs.rsc.org/en/content/articlepdf/2021/MA/D1MA00142F

Reference59 articles.

1. Cancer statistics, 2019

2. Fucose-modified thermoresponsive poly(2-hydroxypropyl methacrylate) nanoparticles for controlled doxorubicin release from an injectable depot

3. Bioinspired fiberboard-and-mortar structural nanocomposite based on ultralong hydroxyapatite nanowires with high mechanical performance